Who owns TRANSCODE THERAPEUTICS INC?
- Ticker: RNAZ
- CUSIP Number: 89357l501
Tip: Access positions for across all investors
Analyze quarterly positions in Transcode Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Transcode Therapeutics stock
Who bought or sold TRANSCODE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Yorkville Advisors Global | 20k | $122k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 6.5k | $41k | 0% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 3.0k | $19k | 0% | Jun 2026 |
|
| UBS Group | 2.9k | $18k | -65% | Jun 2026 |
|
| Mercer Global Advisors | 1.5k | $9.5k | 100% | Jun 2026 |
|
| FMR | 706.00 | $4.4k | 100% | Jun 2026 |
|
| Tower Research Capital | 677.00 | $4.2k | 197% | Jun 2026 |
|
| Wells Fargo & Company | 55.00 | $342.001000 | 0% | Jun 2026 |
|
| SBI Securities | 12.00 | $75.000000 | 0% | Jun 2026 |
|
Who sold out of Transcode Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Geode Capital Management | Mar 2026 | 13k | $110k |